Abivax SA - ESG Rating & Company Profile powered by AI
The webpage is a zero-cost Environmental, Social and Governance analysis covering Abivax SA. Comprehensive Sustainability assessment of Abivax SA are accessed by signing up for free. This Sustainability score for Abivax SA represents its transparency towards the United Nations SDGs.
Abivax SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.0; made up of an environmental score of 2.0, social score of 8.0 and governance score of 8.0.
6.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 483 | Wakamoto Pharmaceutical Co Ltd | 6.1 | High |
| 483 | aTyr Pharma Inc | 6.1 | High |
| 498 | Abivax SA | 6.0 | High |
| 498 | Cann Group Ltd | 6.0 | High |
| 498 | Biosynex SA | 6.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Abivax SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Abivax SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Abivax SA report the average age of the workforce?
Sign up for free to unlockDoes Abivax SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Abivax SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Abivax SA disclose cybersecurity risks?
Sign up for free to unlockDoes Abivax SA offer flexible work?
Sign up for free to unlockDoes Abivax SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Abivax SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Abivax SA conduct supply chain audits?
Sign up for free to unlockDoes Abivax SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Abivax SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Abivax SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Abivax SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Abivax SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Abivax SA disclose water use targets?
Sign up for free to unlockDoes Abivax SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Abivax SA have a product recall in the last two years?
Sign up for free to unlockDoes Abivax SA disclose incidents of discrimination?
Sign up for free to unlockDoes Abivax SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Abivax SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Abivax SA disclose parental leave metrics?
Sign up for free to unlockDoes Abivax SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Abivax SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Abivax SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Abivax SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Abivax SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Abivax SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Abivax SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Abivax SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Abivax SA disclose its waste policy?
Sign up for free to unlockDoes Abivax SA report according to TCFD requirements?
Sign up for free to unlockDoes Abivax SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Abivax SA disclose energy use targets?
Sign up for free to unlockDoes Abivax SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Abivax SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Abivax SA
These potential risks are based on the size, segment and geographies of the company.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.